EAM Investors’s OptiNose OPTN Stock Holding History

EAM Investors’s Portfolio OPTN Stock Details OPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-22,501	Closed	-$1.24M	–	318
2022 Q3	$1.24M	Buy	22,501 +4,779	+27%	+$262K	0.27%	163
2022 Q2	$973K	Buy	+17,722	New	+$652K	0.24%	194
2018 Q3	–	Sell	-2,578	Closed	-$1.08M	–	350
2018 Q2	$1.08M	Buy	+2,578	New	+$869K	0.17%	194

Other funds holding OPTN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

EAM Investors's OPTN Position: Q4 2022 in Review

EAM Investors sold out of OptiNose (OPTN) in Q4 2022, closing a stake of 22,501 shares — an estimated $1.24M sold.

EAM Investors first reported a position in OPTN in Q2 2018 and held it in 3 quarters. The position peaked at $1.24M in Q3 2022. 55 funds tracked by Wall St. Rank hold OPTN as of Q4 2022.

EAM Investors reported no remaining OptiNose position as of Q4 2022 after selling out during the quarter.
EAM Investors sold 22,501 OptiNose shares in Q4 2022, an estimated $1.24M.
EAM Investors first reported a position in OptiNose in Q2 2018 and held it in 3 quarters.
EAM Investors's OptiNose position peaked at $1.24M in Q3 2022.
55 funds tracked by Wall St. Rank held OptiNose as of Q4 2022.

Based on EAM Investors's 13F filing for Q4 2022, filed 14 Feb 2023.